Upcoming Behavioral Health Webinar: Hoops, Hurdles and Holdups: Overcoming Private Insurance Barriers for Behavioral Health Providers. A free, live webinar presented by the Kennedy Forum and U.S. Department of Labor’s Employee Benefits Security Administration. When: June 7, 2023 12:00pm-1:00pm CST Register: Hoops, Hurdles and Holdups
FY23 Final Payment & Data Submission: IDHS/SUPR is issuing this gentle reminder that final FY2023 submissions for all non-Medicaid SUPR funded services are due by 5:00pm on August 7, 2023. All manual vouchers for Expense Based Grants must be submitted by 5:00pm on July 15, 2023. Please share this notification with each applicable staff in your organization. Questions concerning this requirement can be directed to DoIT.SUPRHELP@illinois.gov.
DEA Extension: The Drug Enforcement Agency (DEA) has extended its broader public health emergency telehealth prescribing rules. The pandemic rules which allow prescribers to start treatment with controlled substances via telemedicine are extended through November 11, 2023. The DEA’s new rule took effect on May 12, 2023. Critical to know, patients who have an established telemedicine relationship on or before Nov. 11, 2023, will be extended for an additional year, through Nov. 11, 2024. This is a temporary win for equitable medical treatment since many people were able to receive treatments, including treatment for substance use disorders (SUD) who are homebound or live in areas that are SUD treatment deserts. To read DEA Administrator Milgram’s full statement, please visit COVID-19 Telemedicine Flexibilities.
ASAM Feedback Requested: ASAM is interested in gathering feedback from SUPR’s licensed SUD treatment organizations! The American Society of Addiction Medicine (ASAM) developed and periodically updates The ASAM Criteria, including the ASAM CONTINUUM, which is a standardized, computer guided ASAM Criteria multidimensional assessment software for individuals with substance use disorders (SUDs) and co-occurring conditions. ASAM is seeking feedback to guide the development of CONTINUUM’s next iteration and meet the clinical and technological needs of organization providing services to address SUDs and CODs. With the upcoming release of the ASAM Criteria 4th edition, IDHS/SUPR is sharing information about ASAM’s survey that will help them gain a better understanding of the clinical needs and technological priorities of organizations treating individuals with SUDs and CODs. The survey is 13 questions and should take less than 15 minutes to complete. To complete the survey, please visit ASAM Continuum.
SAMHSA and the FDA have issued a Dear Colleague Letter promoting the Medication First model! To read the full letter, please visit Dear Colleague Letter.